Brief: AtriCure Q2 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.17

AtriCure

30/07/2024 21:01

Jul 30 (Reuters) - AtriCure Q2 gross margin 74.7%.
* Q2 operating income USD -7.2 million vs. IBES estimate USD -6.7 million
* Q2 adjusted EBITDA USD 7.8 million vs. IBES estimate USD 7.41 million
* Q2 revenue USD 116.3 million vs. IBES estimate USD 116.2 million
* Q2 gross profit USD 86.8 million
* outlook FY adjusted EBITDA USD 26-29 million
* outlook FY adjusted EPS USD -0.82 to -0.74